NCT01568307 - Major Depressive Disorder - Understanding The Link Between The Brain And The Heart | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions

Major Depressive Disorder

Interventions

DRUG

Participants will be prescribed an approved selective serotonin re-uptake inhibitor (SSRI) antidepressant.

The choice of SSRI will be based on clinical judgement and prescribed in line with standard dosing approved by the Therapeutic Goods Administration (TGA).

Trial Locations (4)

3004

Alfred and Baker Medical Unit - Alfred Hospital, Melbourne

Baker IDI Heart & Diabetes Institute, Melbourne

3168

Monash Medical Centre - Monash Health, Clayton

3350

Ballarat Health Service Psychiatric Services, Ballarat